Previous close | 69.75 |
Open | 69.55 |
Bid | 86.55 |
Ask | 89.20 |
Strike | 65.00 |
Expiry date | 2024-01-19 |
Day's range | 69.55 - 69.75 |
Contract range | N/A |
Volume | |
Open interest | 45 |
The European Commission approves AbbVie's (ABBV) Tepkinly (epcoritamab) for DLBCL. FDA approves Lilly's (LLY) Jardiance for chronic kidney disease.
Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Oracle, AbbVie, Lowe's Companies, Ecolab and Motorola Solutions are part of the Zacks top Analyst Blog .